Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-8448b6f56d-m8qmq Total loading time: 0 Render date: 2024-04-19T21:28:58.023Z Has data issue: false hasContentIssue false

Section 1 - Epidemiology, Historical Background, Illness Phenomenology, and Diagnostic Issues

Published online by Cambridge University Press:  15 March 2019

Edited by
Carl I. Cohen  and
Paul D. Meesters
Carl I. Cohen
Affiliation:
SUNY Downstate Medical Center
Paul D. Meesters
Affiliation:
Friesland Mental Health Services
Get access
Type
Chapter
Information
Schizophrenia and Psychoses in Later Life
New Perspectives on Treatment, Research, and Policy
 , pp. 1 - 54
Publisher: Cambridge University Press
Print publication year: 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

References

Skoog, I. Dementia: dementia incidence – the times, they are a-changing. Nature Reviews Neurology. 2016; 12(6): 316–18.CrossRefGoogle ScholarPubMed
Howard, R, Rabins, PV, Seeman, MV, Jeste, DV; The International Late-Onset Schizophrenia Group. Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: an international consensus. American Journal of Psychiatry. 2000; 157(2): 172–8.CrossRefGoogle ScholarPubMed
Kendler, KS, Muñoz, RA, Murphy, G. The development of the Feighner criteria: a historical perspective. American Journal of Psychiatry. 2010; 167: 134–42.CrossRefGoogle ScholarPubMed
Kandel, ER. A new intellectual framework for psychiatry. American Journal of Psychiatry. 1998; 155: 457–69.CrossRefGoogle ScholarPubMed
Marková, IS, Berrios, GE. Epistemology of psychiatry. Psychopathology. 2012; 45(4): 220–7.CrossRefGoogle ScholarPubMed
Berrios, GE, Marková, IS. Is the concept of “dimension” applicable to psychiatric objects? World Psychiatry. 2013; 12(1): 76–8.CrossRefGoogle ScholarPubMed
Stanghellini, G. The puzzle of the psychiatric interview. Journal of Phenomenological Psychology. 2004; 35(2): 173–95.CrossRefGoogle Scholar
Brugha, TS, Bebbington, PE, Jenkins, R. A difference that matters: comparisons of structured and semi-structured psychiatric diagnostic interviews in the general population. Psychological Medicine. 1999; 29(5): 1013–20.CrossRefGoogle ScholarPubMed
Kendell, R, Jablensky, A. Distinguishing between the validity and utility of psychiatric diagnoses. American Journal of Psychiatry. 2003; 160(1): 4–12.CrossRefGoogle ScholarPubMed
Spitzer, RL. Psychiatric diagnosis: are clinicians still necessary? Comprehensive Psychiatry. 1983; 24(5): 399–411.CrossRefGoogle ScholarPubMed
van Os, J, Hanssen, M, Bijl, RV, Ravelli, A. Strauss (1969) revisited: a psychosis continuum in the general population? Schizophrenia Research. 2000; 45(1–2): 11–20.CrossRefGoogle ScholarPubMed
Johns, LC, Cannon, M, Singleton, N, et al. Prevalence and correlates of self-reported psychotic symptoms in the British population. British Journal of Psychiatry. 2004; 185: 298–305.CrossRefGoogle ScholarPubMed
Kessler, RC, Birnbaum, H, Demler, O, et al. The prevalence and correlates of nonaffective psychosis in the National Comorbidity Survey Replication (NCS-R). Biological Psychiatry. 2005; 58(8): 668–76.CrossRefGoogle ScholarPubMed
Schultze-Lutter, F, Renner, F, Paruch, J, et al. Self-reported psychotic-like experiences are a poor estimate of clinician-rated attenuated and frank delusions and hallucinations. Psychopathology. 2014; 47(3): 194–201.CrossRefGoogle Scholar
Ochoa, S, Haro, JM, Torres, JV, et al. What is the relative importance of self reported psychotic symptoms in epidemiological studies? Results from the ESEMeD–Catalonia Study. Schizophrenia Research. 2008; 102(1): 261–9.CrossRefGoogle ScholarPubMed
McGrath, JJ, Saha, S, Al-Hamzawi, A, et al. Psychotic experiences in the general population: a cross-national analysis based on 31261 respondents from 18 countries. Journal of the American Medical Association Psychiatry. 2015; 72(7): 697–705.Google Scholar
Nuevo, R, Chatterji, S, Verdes, E, et al. The continuum of psychotic symptoms in the general population: a cross-national study. Schizophrenia Bulletin. 2012; 38(3): 475–85.CrossRefGoogle ScholarPubMed
Bebbington, PE, McBride, O, Steel, C, et al. The structure of paranoia in the general population. British Journal of Psychiatry. 2013; 202: 419–27.CrossRefGoogle ScholarPubMed
David, A. Why we need more debate on whether psychotic symptoms lie on a continuum with normality. Psychological Medicine. 2010; 40(12): 1935–42.CrossRefGoogle ScholarPubMed
Stanghellini, G, Langer, ÁI, Andra Ambrosini, A, Cangas, A.J. Quality of hallucinatory experiences: differences between a clinical and a non-clinical sample. World Psychiatry. 2012; 11(2): 110–13.CrossRefGoogle Scholar
Reinhardt, MM, Cohen, CI. Late-life psychosis: diagnosis and treatment. Current Psychiatry Reports. 2015; 17(2): 1–13.CrossRefGoogle ScholarPubMed
Webster, J, Grossberg, GT. Late-life onset of psychotic symptoms. American Journal of Geriatric Psychiatry. 1998; 6(3): 196–202.CrossRefGoogle ScholarPubMed
Javadpour, A, Sehatpour, M, Mani, A, Sahraian, A. Assessing diagnosis and symptoms profiles of late-life psychosis. GeroPsych. 2013; 26(4): 205.CrossRefGoogle Scholar
Louhija, UM, Saarela, T, Juva, K, Appelberg, B. Brain atrophy is a frequent finding in elderly patients with first episode psychosis. International Psychogeriatrics. 2017; 29(11): 1925–9.CrossRefGoogle ScholarPubMed
Knäuper, B, Wittchen, H-U. Diagnosing major depression in the elderly: evidence for response bias in standardized diagnostic interviews? Journal of Psychiatric Research. 1994; 28(2): 147–64.CrossRefGoogle ScholarPubMed
Copeland, JR, Dewey, ME, Scott, A, et al. Schizophrenia and delusional disorder in older age: community prevalence, incidence, comorbidity, and outcome. Schizophrenia Bulletin. 1998; 24(1): 153–61.CrossRefGoogle ScholarPubMed
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th edn. Arlington, VA: American Psychiatric Association; 2013.Google Scholar
Östling, S, Skoog, I. Psychotic symptoms and paranoid ideation in a nondemented population-based sample of the very old. Archives of General Psychiatry. 2002; 59(1): 53–9.CrossRefGoogle Scholar
Allgulander, C. Psychoactive drug use in a general population sample, Sweden: correlates with perceived health, psychiatric diagnoses, and mortality in an automated record-linkage study. American Journal of Public Health. 1989; 79(8): 1006–10.CrossRefGoogle Scholar
Kessler, RC, Little, RJ, Groves, RM. Advances in strategies for minimizing and adjusting for survey nonresponse. Epidemiologic Reviews. 1995; 17(1): 192–204.CrossRefGoogle ScholarPubMed
Fisher, HL, Caspi, A, Poulton, R, et al. Specificity of childhood psychotic symptoms for predicting schizophrenia by 38 years of age: a birth cohort study. Psychological Medicine. 2013; 43(10): 2077–86.CrossRefGoogle ScholarPubMed
Cohen, P, Cohen, J. The clinician's illusion. Archives of General Psychiatry. 1984; 41(12): 1178–82.CrossRefGoogle ScholarPubMed
Henderson, AS, Korten, AE, Levings, C, et al. Psychotic symptoms in the elderly: a prospective study in a population sample. International Journal of Geriatric Psychiatry. 1998; 13(7): 484–92.3.0.CO;2-7>CrossRefGoogle Scholar
Sigström, R, Skoog, I, Sacuiu, S, et al. The prevalence of psychotic symptoms and paranoid ideation in non‐demented population samples aged 70–82 years. International Journal of Geriatric Psychiatry. 2009; 24(12): 1413–19.CrossRefGoogle ScholarPubMed
Östling, S, Börjesson-Hanson, A, Skoog, I. Psychotic symptoms and paranoid ideation in a population-based sample of 95-year-olds. American Journal of Geriatric Psychiatry. 2007; 15(12): 999–1004.CrossRefGoogle Scholar
Östling, S, Bäckman, K, Waern, M, et al. Paranoid symptoms and hallucinations among the older people in Western Europe. International Journal of Geriatric Psychiatry. 2013; 28(6): 573–9.CrossRefGoogle ScholarPubMed
Soares, WB, Ribeiz, SR, Bassitt, DP, De Oliveira, MC, Bottino, CM. Psychotic symptoms in older people without dementia from a Brazilian community-based sample. International Journal of Geriatric Psychiatry. 2014; 30(5): 437–45.Google ScholarPubMed
Livingston, G, Kitchen, G, Manela, M, Katona, C, Copeland, J. Persecutory symptoms and perceptual disturbance in a community sample of older people: the Islington study. International Journal of Geriatric Psychiatry. 2001; 16(5): 462–8.CrossRefGoogle Scholar
Forsell, Y, Henderson, AS. Epidemiology of paranoid symptoms in an elderly population. British Journal of Psychiatry. 1998; 172: 429–32.CrossRefGoogle Scholar
Christenson, R, Blazer, D. Epidemiology of persecutory ideation in an elderly population in the community. American Journal of Psychiatry. 1984; 141(9): 1088–91.Google Scholar
Cohen, CI, Magai, C, Yaffee, R, Walcott-Brown, L. Racial differences in paranoid ideation and psychoses in an older urban population. American Journal of Psychiatry. 2004; 161(5): 864–71.CrossRefGoogle Scholar
Lyketsos, CG, Steinberg, M, Tschanz, JT, et al. Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging. American Journal of Psychiatry. 2000; 157(5): 708–14.CrossRefGoogle Scholar
Subramaniam, M, Abdin, E, Vaingankar, J, et al. Prevalence of psychotic symptoms among older adults in an Asian population. International Psychogeriatrics. 2016; 28(7): 1211–20.CrossRefGoogle Scholar
Köhler, S, Allardyce, J, Verhey, FR, et al. Cognitive decline and dementia risk in older adults with psychotic symptoms: a prospective cohort study. American Journal of Geriatric Psychiatry. 2013; 21(2): 119–28.CrossRefGoogle ScholarPubMed
Meesters, PD, de Haan, L, Comijs, HC, et al. Schizophrenia spectrum disorders in later life: prevalence and distribution of age at onset and sex in a Dutch catchment area. American Journal of Geriatric Psychiatry. 2012; 20(1): 18–28.CrossRefGoogle Scholar
Perälä, J, Suvisaari, J, Saarni, SI, et al. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Archives of General Psychiatry. 2007; 64(1): 19–28.CrossRefGoogle ScholarPubMed
Skoog, I, Nilsson, L, Landahl, S, Steen, B. Mental disorders and the use of psychotropic drugs in an 85-year-old urban population. International Psychogeriatrics. 1993; 5(1): 33–48.CrossRefGoogle Scholar
Saha, S, Chant, D, McGrath, J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Archives of General Psychiatry. 2007; 64(10): 1123–31.CrossRefGoogle ScholarPubMed
Soares, WB, Dos Santos, EB, Bottino, CMC, Elkis, H. Psychotic symptoms in older people without dementia from a Brazilian community-based sample: a seven years' follow-up. PLoS One. 2017; 12(6): e0178471.CrossRefGoogle Scholar
Östling, S, Palsson, SP, Skoog, I. The incidence of first-onset psychotic symptoms and paranoid ideation in a representative population sample followed from age 70-90 years. Relation to mortality and later development of dementia. International Journal of Geriatric Psychiatry. 2007; 22(6): 520–8.CrossRefGoogle Scholar
Stafford, J, Howard, R, Kirkbride, JB. The incidence of very late-onset psychotic disorders: a systematic review and meta-analysis, 1960–2016. Psychological Medicine. 2017: 1–12.Google ScholarPubMed
Pedersen, CB, Mors, O, Bertelsen, A, et al. A comprehensive nationwide study of the incidence rate and lifetime risk for treated mental disorders. Journal of the American Medical Association Psychiatry. 2014; 71(5): 573–81.Google ScholarPubMed
McGrath, J, Saha, S, Welham, J, El Saadi, O, MacCauley, C, Chant, D. A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. British Medical Council Medicine. 2004; 2(1): 13.Google ScholarPubMed
Castle, DJ, Murray, RM. The epidemiology of late-onset schizophrenia. Schizophrenia Bulletin. 1993; 19(4): 691–700.CrossRefGoogle ScholarPubMed
Almeida, OP, Howard, RJ, Levy, R, David, AS. Psychotic states arising in late life (late paraphrenia): the role of risk factors. The British Journal of Psychiatry. 1995; 166(2): 215–28.Google ScholarPubMed
Östling, S, Andreasson, LA, Skoog, I. Basal ganglia calcification and psychotic symptoms in the very old. International Journal of Geriatric Psychiatry. 2003; 18(11): 983–7.CrossRefGoogle ScholarPubMed
Brunelle, S, Cole, MG, Elie, M. Risk factors for the late‐onset psychoses: a systematic review of cohort studies. International Journal of Geriatric Psychiatry. 2012; 27(3): 240–52.CrossRefGoogle ScholarPubMed
Hill, AB. The environment and disease: association or causation? Proceedings of the Royal Society of Medicine. 1965; 58(5): 295.CrossRefGoogle ScholarPubMed
Meesters, PD, Comijs, HC, Smit, JH, et al. Mortality and its determinants in late-life schizophrenia: a 5-year prospective study in a Dutch catchment area. American Journal of Geriatric Psychiatry. 2016; 24(4): 272–7.CrossRefGoogle Scholar
Talaslahti, T, Alanen, HM, Hakko, H, et al. Mortality and causes of death in older patients with schizophrenia. International Journal of Geriatric Psychiatry. 2012; 27(11): 1131–7.CrossRefGoogle ScholarPubMed
Talaslahti, T, Alanen, HM, Hakko, H, et al. Patients with very-late-onset schizoprhenia-like psychosis have higher mortality rates than elderly patients with earlier onset schizophrenia. International Journal of Geriatric Psychiatry. 2015; 30(5): 453–9.CrossRefGoogle ScholarPubMed
Kredentser, MS, Martens, PJ, Chochinov, HM, Prior, HJ. Cause and rate of death in people with schizophrenia across the lifespan: a population-based study in Manitoba, Canada. Journal of Clinical Psychiatry. 2014; 75(2): 154–61.Google ScholarPubMed
Almeida, OP, Hankey, GJ, Yeap, BB, et al. Mortality among people with severe mental disorders who reach old age: a longitudinal study of a community-representative sample of 37892 men. PloS One. 2014; 9(10): e111882.CrossRefGoogle ScholarPubMed
Ribe, AR, Laursen, TM, Charles, M, et al. Long-term risk of dementia in persons with schizophrenia: a Danish population-based cohort study. Journal of the American Medical Association Psychiatry. 2015; 72(11): 1095–101.Google ScholarPubMed
Kørner, A, Lopez, AG, Lauritzen, L, Andersen, PK, Kessing, LV. Late and very‐late first‐contact schizophrenia and the risk of dementia – a nationwide register based study. International Journal of Geriatric Psychiatry. 2009; 24(1): 61–7.CrossRefGoogle ScholarPubMed
Kørner, A, Lopez, AG, Lauritzen, L, Andersen, PK, Kessing, LV. Delusional disorder in old age and the risk of developing dementia – a nationwide register-based study. Aging and Mental Health. 2008; 12(5): 625–9.Google ScholarPubMed
Roth, M. The natural history of mental disorder in old age. The British Journal of Psychiatry. 1955; 101(423): 281–301.Google ScholarPubMed
Ritchie, K, Artero, S, Beluche, I, et al. Prevalence of DSM-IV psychiatric disorder in the French elderly population. British Journal of Psychiatry. 2004; 184: 147–52.CrossRefGoogle ScholarPubMed

References

Hjorthoj, C., Sturup, A. E., McGrath, J. J., et al. Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis. Lancet Psychiatry 2017; 4: 295–301.CrossRefGoogle ScholarPubMed
Berry, K. and Barrowclough, C.. The needs of older adults with schizophrenia: implications for psychological interventions. Clinical Psychology Review 2009; 29(1): 68–76.CrossRefGoogle ScholarPubMed
Cohen, C. I. and GAP Committee on Aging. Practical geriatrics: directions for research and policy on schizophrenia and older adults: summary of the GAP committee report. Psychiatric Services 2000; 51(3): 299–302.CrossRefGoogle ScholarPubMed
Cohen, C. I., Meesters, P. D. and Zhao, J.. New perspectives on schizophrenia in later life: implications for treatment, policy, and research. Lancet Psychiatry 2015; 2(4): 340–50.CrossRefGoogle ScholarPubMed
Whiteford, H. A., Degenhardt, L., Rehm, J., et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet 2013; 382(9904): 1575–86.CrossRefGoogle ScholarPubMed
Chong, H. Y., Teoh, S. L., Wu, D. B., et al. Global economic burden of schizophrenia: a systematic review. Neuropsychiatric Disease and Treatment 2016; 12: 357–73.Google ScholarPubMed
Cloutier, M., Aigbogun, M. S., Guerin, A., et al. The economic burden of schizophrenia in the United States in 2013. Journal of Clinical Psychiatry 2016; 77(6): 764–71.Google ScholarPubMed
Bartels, S. J., Clark, R. E., Peacock, W. J., et al. Medicare and Medicaid costs for schizophrenia patients by age cohort compared with costs for depression, dementia, and medically ill patients. American Journal of Geriatric Psychiatry 2003; 11(6): 648–57.CrossRefGoogle ScholarPubMed
Howard, R., Rabins, P. V., Seeman, M. V., et al. Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: an international consensus. American Journal of Psychiatry 2000; 157(2): 172–8.CrossRefGoogle ScholarPubMed
Keith, S. J., Regier, D. A. and Rae, D. S.. Schizophrenic disorders. In Psychiatric Disorders in America: The Epidemiologic Catchment Area Study, ed Robins, L. N. and Regier, D. A.. New York: Free Press, 1991, 33–52.Google Scholar
Palmer, B. W., Heaton, S. C. and Jeste, D. V.. Older patients with schizophrenia: challenges in the coming decades. Psychiatric Services 1999; 50(9): 1178–83.CrossRefGoogle ScholarPubMed
Kessler, R. C., Birnbaum, H., Demler, O., et al. The prevalence and correlates of non-affective psychosis in the National Comorbidity Survey Replication (NCS-R). Biological Psychiatry 2005; 58(8): 668–76.CrossRefGoogle Scholar
Wu, E. Q., Shi, L., Birnbaum, H., et al. Annual prevalence of diagnosed schizophrenia in the USA: a claims data analysis approach. Psychological Medicine 2006; 36(11): 1535–40.CrossRefGoogle Scholar
Mechanic, D., McAlpine, D. D. and Rochefort, D. A.. Mental Health and Social Policy: Beyond Managed Care. Boston, MA: Pearson Education, 2014.Google Scholar
Frank, R. G.. The creation of Medicare and Medicaid: the emergence of insurance and markets for mental health services. Psychiatric Services 2000; 51(4): 465–8.CrossRefGoogle ScholarPubMed
Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. Mental Health Annual Report: 2014. National Use of Mental Health Services. HHS Publication No.17-5033, 2017.Google Scholar
Manderscheid, R. W., Atay, J. E. and Crider, R. A.. Changing trends in state psychiatric hospital use from 2002 to 2005. Psychiatric Services 2009; 60(1): 29–34.CrossRefGoogle ScholarPubMed
Mechanic, D., McAlpine, D. D. and Olfson, M.. Changing patterns of psychiatric inpatient care in the United States, 1988–1994. Archives of General Psychiatry 1998; 55(9): 785–91.CrossRefGoogle ScholarPubMed
Owens, P., Myers, M., Elixhauser, A., et al. Care of Adults with Mental Health and Substance Abuse Disorders in US Community Hospitals, 2004. HCUP Fact Book No. 10. Rockville, MD: Agency for Healthcare Research and Quality, 2007.Google Scholar
Hoover, D. R., Akincigil, A., Prince, J. D., et al. Medicare inpatient treatment for elderly non-dementia psychiatric illnesses 1992–2002; length of stay and expenditures by facility type. Administration and Policy in Mental Health and Mental Health Services Research 2008; 35(4): 231–40.CrossRefGoogle ScholarPubMed
Agency for Healthcare Research and Quality. Healthcare Cost and Utilization Project (HCUP), Nationwide Inpatient Sample (NIS), 2011.Google Scholar
Bowersox, N. W., Szymanski, B. J. and McCarthy, J. F.. Associations between psychiatric inpatient bed supply and the prevalence of serious mental illness in Veterans Affairs nursing homes. American Journal of Public Health 2013; 103(7): 1325–31.CrossRefGoogle ScholarPubMed
Avorn, J., Dreyer, P., Connelly, K., et al. Use of psychoactive medication and the quality of care in rest homes: findings and policy implications of a statewide study. New England Journal of Medicine 1989; 320(4): 227–32.CrossRefGoogle ScholarPubMed
Kruzich, J. M.. The chronically mentally ill in nursing homes: issues in policy and practice. Health and Social Work 1986; 11(1): 5–14.CrossRefGoogle ScholarPubMed
Schmidt, L. J., Reinhardt, A. M. and Kane, R. L.. The mentally ill in nursing homes: new back wards in the community. Archives of General Psychiatry 1977; 34(6): 687–91.CrossRefGoogle ScholarPubMed
Reichman, W. E., Coyne, A. C., Borson, S., et al. Psychiatric consultation in the nursing home: a survey of six states. American Journal of Geriatric Psychiatry 1998; 6(4): 320–7.Google ScholarPubMed
Freedman, R. I. and Moran, A.. Wanderers in a promised land: the chronically mentally ill and deinstitutionalization. Medical Care 1984; 22(12 Suppl): S1–60.CrossRefGoogle Scholar
Institute of Medicine. Improving the Quality of Care in Nursing Homes. Washington, DC: The National Academies Press, 1986.Google Scholar
Hawes, C., Mor, V., Phillips, C. D., et al. The OBRA-87 nursing home regulations and implementation of the Resident Assessment Instrument: effects on process quality. Journal of the American Geriatrics Society 1997; 45(8): 977–85.CrossRefGoogle ScholarPubMed
Mechanic, D. and McAlpine, D. D.. Use of nursing homes in the care of persons with severe mental illness: 1985 to 1995. Psychiatric Services 2000; 51(3): 354–8.CrossRefGoogle ScholarPubMed
Andrews, A. O., Bartels, S. J., Xie, H., et al. Increased risk of nursing home admission among middle aged and older adults with schizophrenia. American Journal of Geriatric Psychiatry 2009; 17(8): 697–705.CrossRefGoogle ScholarPubMed
Shea, D. G., Russo, P. A. and Smyer, M. A.. Use of mental health services by persons with a mental illness in nursing facilities: initial impacts of OBRA87. Journal of Aging and Health 2000; 12(4): 560–78.CrossRefGoogle ScholarPubMed
Llorente, M. D., Olsen, E. J., Leyva, O., et al. Use of antipsychotic drugs in nursing homes: current compliance with OBRA regulations. Journal of the American Geriatrics Society 1998; 46(2): 198–201.CrossRefGoogle ScholarPubMed
Wang, P. S., Lane, M., Olfson, M., et al. Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication. Archives of General Psychiatry 2005; 62(6): 629–40.CrossRefGoogle ScholarPubMed
Karlin, B. E., Duffy, M. and Gleaves, D. H.. Patterns and predictors of mental health service use and mental illness among older and younger adults in the United States. Psychological Services 2008; 5(3): 275.CrossRefGoogle Scholar
Dixon, L., Lyles, A., Smith, C., et al. Use and costs of ambulatory care services among Medicare enrollees with schizophrenia. Psychiatric Services 2001; 52(6): 786–92.CrossRefGoogle ScholarPubMed
Laursen, T. M., Nordentoft, M. and Mortensen, P. B.. Excess early mortality in schizophrenia. Annual Review of Clinical Psychology 2014; 10: 425–48.CrossRefGoogle ScholarPubMed
Olfson, M., Gerhard, T., Huang, C., et al. Premature mortality among adults with schizophrenia in the United States. JAMA Psychiatry 2015; 72(12): 1172–81.CrossRefGoogle ScholarPubMed
Henderson, D. C.. Schizophrenia and comorbid metabolic disorders. Journal of Clinical Psychiatry 2004; 66: 11–20.Google Scholar
Hendrie, H. C., Tu, W., Tabbey, R., et al. Health outcomes and cost of care among older adults with schizophrenia: a 10-year study using medical records across the continuum of care. American Journal of Geriatric Psychiatry 2014; 22(5): 427–36.CrossRefGoogle ScholarPubMed
Lord, O., Malone, D. and Mitchell, A. J.. Receipt of preventive medical care and medical screening for patients with mental illness: a comparative analysis. General Hospital Psychiatry 2010; 32(5): 519–43.CrossRefGoogle ScholarPubMed
Bradford, D. W., Kim, M. M., Braxton, L. E., et al. Access to medical care among persons with psychotic and major affective disorders. Psychiatric Services 2008; 59(8): 847–52.CrossRefGoogle ScholarPubMed
Vahia, I. V., Diwan, S., Bankole, A. O., et al. Adequacy of medical treatment among older persons with schizophrenia. Psychiatric Services 2008; 59(8): 853–9.CrossRefGoogle ScholarPubMed
Lindamer, L. A., Bailey, A., Hawthorne, W., et al. Gender differences in characteristics and service use of public mental health patients with schizophrenia. Psychiatric Services 2003; 54(10): 1407–9.CrossRefGoogle ScholarPubMed
Butler, M., Kane, R. L., McAlpine, D., et al. Integration of mental health/substance abuse and primary care. AHRQ Evidence Report 2008; 173: 1–362.Google Scholar
Reilly, S., Planner, C., Gask, L., et al. Collaborative care approaches for people with severe mental illness. Cochrane Database of Systematic Reviews 2013(11): CD009531.Google ScholarPubMed
Bao, Y., Casalino, L. P. and Pincus, H. A.. Behavioral health and health care reform models: patient-centered medical home, health home, and accountable care organization. Journal of Behavioral Health Services and Research 2013; 40(1): 121–32.CrossRefGoogle ScholarPubMed
Domino, M. E., Wells, R. and Morrissey, J. P.. Serving persons with severe mental illness in primary care-based medical homes. Psychiatric Services 2015; 66(5): 477–83.CrossRefGoogle ScholarPubMed
Rosenheck, R., Leslie, D., Keefe, R., et al. Barriers to employment for people with schizophrenia. American Journal of Psychiatry 2006; 163(3): 411–7.CrossRefGoogle ScholarPubMed
Khaykin, E., Eaton, W. W., Ford, D. E., et al. Health insurance coverage among persons with schizophrenia in the United States. Psychiatric Services 2010; 61(8): 830–4.CrossRefGoogle ScholarPubMed
Feldman, R., Bailey, R. A., Muller, J., et al. Cost of schizophrenia in the Medicare program. Population Health Management 2014; 17(3): 190–6.CrossRefGoogle ScholarPubMed
Zhang, Y., Baik, S. H. and Newhouse, J. P.. Use of intelligent assignment to Medicare Part D plans for people with schizophrenia could produce substantial savings. Health Affairs 2015; 34(3): 455–60.CrossRefGoogle ScholarPubMed
Li, Y., Cai, X. and Cram, P.. Are patients with serious mental illness more likely to be admitted to nursing homes with more deficiencies in care? Medical Care 2011; 49(4): 397–405.CrossRefGoogle ScholarPubMed
Rahman, M., Grabowski, D. C., Gozalo, P. L., et al. Are dual eligibles admitted to poorer quality skilled nursing facilities? Health Services Research 2014; 49(3): 798–817.CrossRefGoogle ScholarPubMed
Rahman, M., Grabowski, D. C., Intrator, O., et al. Serious mental illness and nursing home quality of care. Health Services Research 2013; 48(4): 1279–98.CrossRefGoogle ScholarPubMed
Mor, V., Gruneir, A., Feng, Z., et al. The effect of state policies on nursing home resident outcomes. Journal of the American Geriatrics Society 2011; 59(1): 3–9.CrossRefGoogle ScholarPubMed
Madden, J. M., Adams, A. S., LeCates, R. F., et al. Changes in drug coverage generosity and untreated serious mental illness: transitioning from Medicaid to Medicare Part D. JAMA Psychiatry 2015; 72(2): 179–88.CrossRefGoogle ScholarPubMed
West, J. C., Wilk, J. E., Rae, D. S., et al. First-year Medicare Part D prescription drug benefits: medication access and continuity among dual eligible psychiatric patients. Journal of Clinical Psychiatry 2010; 71(4): 400–10.Google ScholarPubMed
Beronio, K., Glied, S. and Frank, R.. How the Affordable Care Act and Mental Health Parity and Addiction Equity Act greatly expand coverage of behavioral health care. Journal of Behavioral Health Services and Research 2014; 41(4): 410–28.CrossRefGoogle ScholarPubMed
Goldman, H. H.. Will health insurance reform in the United States help people with schizophrenia? Schizophrenia Bulletin 2010; 36(5): 893–4.CrossRefGoogle ScholarPubMed
Bartlett, J. and Manderscheid, R.. What does mental health parity really mean for the care of people with serious mental illness? Psychiatric Clinics of North America 2016; 39(2): 331–42.CrossRefGoogle ScholarPubMed
Ostrow, L. and Manderscheid, R.. Medicare mental health parity: a high potential change that is long overdue. Journal of Behavioral Health Services and Research 2010; 37(3): 285–90.CrossRefGoogle ScholarPubMed

References

Arciniegas, D.B., Psychosis. Continuum: Lifelong Learning in Neurology, 2015. 21(3 Behavioral Neurology and Neuropsychiatry): p. 715.Google ScholarPubMed
Holroyd, S. and Laurie, S., Correlates of psychotic symptoms among elderly outpatients. International Journal of Geriatric Psychiatry, 1999. 14(5): p. 379–84.3.0.CO;2-7>CrossRefGoogle ScholarPubMed
Karim, S. and Byrne, E.J., Treatment of psychosis in elderly people. Advances in Psychiatric Treatment, 2005. 11: p. 286–96.CrossRefGoogle Scholar
Sigström, R., Skoog, I., Sacuiu, S., et al., The prevalence of psychotic symptoms and paranoid ideation in non-demented population samples aged 70–82 years. International Journal of Geriatric Psychiatry, 2009. 24(12): p. 1413–19.CrossRefGoogle ScholarPubMed
Subramaniam, M., Abdin, E., Vaingankar, J., et al., Prevalence of psychotic symptoms among older adults in an Asian population. International Psychogeriatrics, 2016. 28(7): p. 1211–20.CrossRefGoogle Scholar
Soares, W.B., Ribeiz, S.R.I., Bassitt, D.P., De Oliveira, M.C., and Bottino, C.M.C., Psychotic symptoms in older people without dementia from a Brazilian community-based sample. International Journal of Geriatric Psychiatry, 2015. 30(5): p. 437–45.CrossRefGoogle ScholarPubMed
Cohen, C.I., Magai, C., Yaffee, R., and Walcott-Brown, L., Racial differences in paranoid ideation and psychoses in an older urban population. American Journal of Psychiatry, 2004. 161(5): p. 864–71.CrossRefGoogle Scholar
Manepalli, J.N., Gebretsadik, M., Hook, J., and Grossberg, G., Differential diagnosis of the older patient with psychotic symptoms. Primary Psychiatry, 2007. 14(8): p. 55–62.Google Scholar
Webster, J. and Grossberg, G.T., Late-life onset of psychotic symptoms. American Journal of Geriatric Psychiatry, 1998. 6(3): p. 196–202.CrossRefGoogle ScholarPubMed
Reinhardt, M.M. and Cohen, C.I., Late-life psychosis: diagnosis and treatment. Current Psychiatry Reports, 2015. 17(2): p. 1.CrossRefGoogle ScholarPubMed
American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders (DSM-5®). 2013, Arlington, VA: American Psychiatric Association.Google Scholar
Christenson, R. and Blazer, D., Epidemiology of persecutory ideation in an elderly population in the community. American Journal of Psychiatry, 1984. 141(9): p. 1088–91.Google Scholar
Östling, S., Bäckman, K., Waern, M., et al., Paranoid symptoms and hallucinations among the older people in Western Europe. International Journal of Geriatric Psychiatry, 2013. 28(6): p. 573–9.CrossRefGoogle ScholarPubMed
Ciompi, L., Catamnestic long-term study on the course of life and aging of schizophrenics. Schizophrenia Bulletin, 1980. 6(4): p. 606.CrossRefGoogle ScholarPubMed
American Psychiatric Association, The American Association of Psychiatry Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients with Dementia. 2016, Arlington, VA: American Psychiatric Association.Google Scholar
Inouye, S.K., Westendorp, R.G.J., and Saczynski, J.S., Delirium in elderly people. Lancet, 2014. 383(9920): p. 911–22.Google ScholarPubMed
Oh, E.S., Fong, T.G., Hshieh, T.T., et al., Delirium in older persons: advances in diagnosis and treatment. Journal of the American Medical Association, 2017. 318(12): p. 1161–74.Google ScholarPubMed
Inouye, S.K., van Dyck, C.H., Alessi, C.A., et al., Clarifying confusion: the confusion assessment method: a new method for detection of delirium. Annals of Internal Medicine, 1990. 113(12): p. 941–8.CrossRefGoogle Scholar
Boettger, S. and Breitbart, W., Phenomenology of the subtypes of delirium: phenomenological differences between hyperactive and hypoactive delirium. Palliative and Supportive Care, 2011. 9(2): p. 129–35.CrossRefGoogle ScholarPubMed
Meagher, D.J., Moran, M., Raju, B., et al., Phenomenology of delirium: assessment of 100 adult cases using standardised measures. British Journal of Psychiatry, 2007. 190: p. 135–41.CrossRefGoogle ScholarPubMed
Webster, R. and Holroyd, S., Prevalence of psychotic symptoms in delirium. Psychosomatics, 2000. 41(6): p. 519–22.CrossRefGoogle ScholarPubMed
Inouye, S.K., Kosar, C.M., Tommet, D., et al., The CAM-S: development and validation of a new scoring system for delirium severity in 2 cohorts. Annals of Internal Medicine, 2014. 160(8): p. 526–33.CrossRefGoogle ScholarPubMed
Bellelli, G., Morandi, A., Davis, D.H.J., et al., Validation of the 4AT, a new instrument for rapid delirium screening: a study in 234 hospitalised older people. Age and Ageing, 2014. 43(4): p. 496–502.CrossRefGoogle ScholarPubMed
Marcantonio, E.R., Ngo, L.H., O'Connor, M., et al., 3D-CAM: derivation and validation of a 3-minute diagnostic interview for CAM-defined delirium: a cross-sectional diagnostic test study. Annals of Internal Medicine, 2014. 161(8): p. 554–61.CrossRefGoogle ScholarPubMed
Steis, M.R., Evans, L., Hirschman, K.B., et al., Screening for delirium using family caregivers: convergent validity of the Family Confusion Assessment Method and interviewer-rated confusion assessment method. Journal of the American Geriatrics Society, 2012. 60(11): p. 2121–6.CrossRefGoogle ScholarPubMed
Lipowski, Z., Delirium: Acute Confusional States. 1990, New York: Oxford University Press, p. 97.Google Scholar
Morandi, A., Di Santo, S.G., Cherubini, A., et al., Clinical features associated with delirium motor subtypes in older inpatients: results of a multicenter study. American Journal of Geriatric Psychiatry. 25(10): p. 1064–71.Google Scholar
Witlox, J., Eurelings, L.S.M., de Jonghe, J.F.M., et al., Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia: a meta-analysis. Journal of the American Medical Association, 2010. 304(4): p. 443–51.Google ScholarPubMed
Siddiqi, N., Harrison, J.K., Clegg, A., et al., Interventions for preventing delirium in hospitalised non-ICU patients. Cochrane Database of Systematic Reviews, 2016: CD005563.Google ScholarPubMed
Ropacki, S.A. and Jeste, D.V., Epidemiology of and risk factors for psychosis of Alzheimer's disease: a review of 55 studies published from 1990 to 2003. American Journal of Psychiatry, 2005. 162(11): p. 2022–30.CrossRefGoogle ScholarPubMed
Scarmeas, N., Brandt, J., Albert, M., et al., Delusions and hallucinations are associated with worse outcome in Alzheimer disease. Archives of Neurology, 2005. 62(10): p. 1601–8.CrossRefGoogle ScholarPubMed
Murray, P.S., Kumar, S., Demichele-Sweet, M.A., and Sweet, R.A., Psychosis in Alzheimer's disease. Biological Psychiatry, 2014. 75(7): p. 542–52.CrossRefGoogle ScholarPubMed
Connors, M.H., Ames, D., Woodward, M., and Brodaty, H., Psychosis and clinical outcomes in Alzheimer disease: a longitudinal study. American Journal of Geriatric Psychiatry. 26(3): p. 304–13.Google Scholar
Kales, H.C., Gitlin, L.N., and Lyketsos, C.G., Assessment and management of behavioral and psychological symptoms of dementia. British Medical Journal, 2015. 350: p. h369.CrossRefGoogle ScholarPubMed
Brodaty, H. and Arasaratnam, C., Meta-analysis of nonpharmacological interventions for neuropsychiatric symptoms of dementia. American Journal of Psychiatry, 2012. 169(9): p. 946–53.CrossRefGoogle ScholarPubMed
Clare, L., Woods, R.T., Moniz Cook, E.D., Orrell, M., and Spector, A., Cognitive rehabilitation and cognitive training for early-stage Alzheimer's disease and vascular dementia. Cochrane Database of Systematic Reviews, 2003. (4): CD003260.Google ScholarPubMed
Forbes, D., Culum, I., Lischka, A.R., et al., Light therapy for managing cognitive, sleep, functional, behavioural, or psychiatric disturbances in dementia. Cochrane Database of Systematic Reviews, 2009(4): CD003946.Google ScholarPubMed
Thorgrimsen, L., Birks, T.P.H., Thorgrimsen, L.M., et al., Aroma therapy for dementia. Cochrane Database of Systematic Reviews, 2003(3): CD003150.Google ScholarPubMed
Rodda, J., Morgan, S., and Walker, Z., Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine. International Psychogeriatrics, 2009. 21(5): p. 813–24.CrossRefGoogle ScholarPubMed
Trinh, N.H., Hoblyn, J., Mohanty, S., and Yaffe, K., Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis. Journal of the American Medical Association, 2003. 289(2): p. 210–16.Google ScholarPubMed
Rolinski, M., Fox, C., Maidment, I., and McShane, R., Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease. Cochrane Database of Systematic Reviews, 2012(3): CD006504.Google ScholarPubMed
Cumbo, E. and Ligori, L.D., Differential effects of current specific treatments on behavioral and psychological symptoms in patients with Alzheimer's disease: a 12-month, randomized, open-label trial. Journal of Alzheimer's Disease, 2014. 39(3): p. 477–85.CrossRefGoogle ScholarPubMed
Gauthier, S., Loft, H., and Cummings, J., Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis. International Journal of Geriatric Psychiatry, 2008. 23(5): p. 537–45.CrossRefGoogle ScholarPubMed
Lachaine, J., Beauchemin, C., Crochard, A., and Bineau, S., The impact of memantine and cholinesterase inhibitor initiation for Alzheimer disease on the use of antipsychotic agents: analysis using the Regie de l'Assurance Maladie du Quebec Database. Canadian Journal of Psychiatry, 2013. 58(4): p. 195–200.CrossRefGoogle ScholarPubMed
Gauthier, S., Wirth, Y., and Mobius, H.J., Effects of memantine on behavioural symptoms in Alzheimer's disease patients: an analysis of the Neuropsychiatric Inventory (NPI) data of two randomised, controlled studies. International Journal of Geriatric Psychiatry, 2005. 20(5): p. 459–64.CrossRefGoogle ScholarPubMed
Wilcock, G.K., Ballard, C.G., Cooper, J.A., and Loft, H., Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies. Journal of Clinical Psychiatry, 2008. 69(3): p. 341–8.Google ScholarPubMed
McShane, R., Areosa Sastre, A., and Minakaran, N., Memantine for dementia. Cochrane Database of Systematic Reviews, 2006(2): CD003154.Google ScholarPubMed
Jeste, D.V., Blazer, D., Casey, D., et al., ACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementia. Neuropsychopharmacology, 2008. 33(5): p. 957–70.CrossRefGoogle ScholarPubMed
Schneider, L.S., Dagerman, K., and Insel, P.S., Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials. American Journal of Geriatric Psychiatry, 2006. 14(3): p. 191–210.CrossRefGoogle ScholarPubMed
Schneider, L.S., Dagerman, K.S., and Insel, P., Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. Journal of the American Medical Association, 2005. 294(15): p. 1934–43.Google ScholarPubMed
Jeste, D.V., Barak, Y., Madhusoodanan, S., Grossman, F., and Gharabawi, G., International multisite double-blind trial of the atypical antipsychotics risperidone and olanzapine in 175 elderly patients with chronic schizophrenia. American Journal of Geriatric Psychiatry, 2003. 11(6): p. 638–47.CrossRefGoogle ScholarPubMed
Cummings, J., Isaacson, S., Mills, R., et al., Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial. Lancet, 2014. 383(9916): p. 533–40.CrossRefGoogle ScholarPubMed
Fox, S.H., Pimavanserin as treatment for Parkinson's disease psychosis. Lancet, 2014. 383(9916): p. 494–6.CrossRefGoogle ScholarPubMed
Maher, A.R., Maglione, M., Bagley, S., et al., Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis. Journal of the American Medical Association, 2011. 306(12): p. 1359–69.Google ScholarPubMed
Meeks, T.W. and Jeste, D.V., Beyond the black box: what is the role for antipsychotics in dementia? Current Psychiatry, 2008. 7(6): p. 50–65.Google ScholarPubMed
Seitz, D.P., Adunuri, N., Gill, S.S., et al., Antidepressants for agitation and psychosis in dementia. Cochrane Database of Systematic Reviews, 2011(2): CD008191.Google ScholarPubMed
Finkel, S.I., Mintzer, J.E., Dysken, M., et al., A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil. International Journal of Geriatric Psychiatry, 2004. 19(1): p. 9–18.CrossRefGoogle ScholarPubMed
Pollock, B.G., Mulsant, B.H., Rosen, J., et al., A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia. American Journal of Geriatric Psychiatry, 2007. 15(11): p. 942–52.CrossRefGoogle ScholarPubMed
Porsteinsson, A.P., Drye, L.T., Pollock, B.G., et al., Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial. Journal of the American Medical Association, 2014. 311(7): p. 682–91.Google ScholarPubMed
Alexopoulos, G.S., Streim, J.E., and Carpenter, D., Commentary: expert consensus guidelines for using antipsychotic agents in older patients. The Journal of Clinical Psychiatry, 2004. 65(suppl 2): p. 100–2.Google Scholar
American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders (DSM-5®). 2013, Arlington, VA: American Psychiatric Association.Google Scholar
Brunelle, S., Cole, M.G., and Elie, M., Risk factors for the late-onset psychoses: a systematic review of cohort studies. International Journal of Geriatric Psychiatry, 2012. 27(3): p. 240–52.CrossRefGoogle ScholarPubMed
Howard, R., Rabins, P.V., Seeman, M.V., and Jeste, D.V., Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: An international consensus. American Journal of Psychiatry, 2000. 157(2): p. 172–8.CrossRefGoogle ScholarPubMed
Stafford, J., Howard, R., and Kirkbride, J.B., The incidence of very late-onset psychotic disorders: a systematic review and meta-analysis, 1960-2016. Psychological Medicine, 2017: p. 1–2.Google ScholarPubMed
Cohen, C.I., Meesters, P.D., and Zhao, J., New perspectives on schizophrenia into later life: Implications for treatment, policy, and research. Lancet Psychiatry, 2015. 2(4): p. 340–50.CrossRefGoogle ScholarPubMed
Palmer, B.W., McClure, F.S., and Jeste, D.V., Schizophrenia in late life: findings challenge traditional concepts. Harvard Review of Psychiatry, 2001. 9(2): p. 51–8.CrossRefGoogle ScholarPubMed
Vahia, I.V., Palmer, B.W., Depp, C., et al., Is late‐onset schizophrenia a subtype of schizophrenia? Acta Psychiatrica Scandinavica, 2010. 122(5): p. 414–26.CrossRefGoogle ScholarPubMed
Iglewicz, A., Meeks, T.W., and Jeste, D.V., New wine in old bottle: late-life psychosis. Psychiatric Clinics of North America, 2011. 34(2): p. 295–318.CrossRefGoogle ScholarPubMed
Howard, R., Almeida, O., and Levy, R., Phenomenology, demography and diagnosis in late paraphrenia. Psychological Medicine, 1994. 24(02): p. 397–410.CrossRefGoogle ScholarPubMed
Essali, A. and Ali, G., Antipsychotic drug treatment for elderly people with late-onset schizophrenia. Cochrane Database of Systematic Reviews, 2012. (2): CD004162.Google ScholarPubMed
Marriott, R.G., Neil, W., and Waddingham, S., Antipsychotic medication for elderly people with schizophrenia. Cochrane Database of Systematic Reviews, 2006(1): CD005580.Google ScholarPubMed
Suzuki, T., Remington, G., Uchida, H., et al., Management of schizophrenia in late life with antipsychotic medications: a qualitative review. Drugs and Aging, 2011. 28(12): p. 961–80.CrossRefGoogle ScholarPubMed
Tzimos, A., Samokhvalov, V., Kramer, M., et al., Safety and tolerability of oral paliperidone extended-release tablets in elderly patients with schizophrenia: a double-blind, placebo-controlled study with six-month open-label extension. American Journal of Geriatric Psychiatry, 2008. 16(1): p. 31–43.CrossRefGoogle ScholarPubMed
Graff-Guerrero, A., Rajji, T.K., Mulsant, B.H., et al., Evaluation of antipsychotic dose reduction in late-life schizophrenia: a prospective dopamine D2/3 receptor occupancy study. JAMA Psychiatry, 2015. 72(9): p. 927–34.CrossRefGoogle ScholarPubMed
Granholm, E., McQuaid, J.R., McClure, F.S., et al., A randomized, controlled trial of cognitive behavioral social skills training for middle-aged and older outpatients with chronic schizophrenia. American Journal of Psychiatry, 2005. 162(3): p. 520–9.CrossRefGoogle ScholarPubMed
Granholm, E., McQuaid, J.R., McClure, F.S., et al., Randomized controlled trial of cognitive behavioral social skills training for older people with schizophrenia: 12-month follow-up. Journal of Clinical Psychiatry, 2007. 68(5): p. 730–7.Google Scholar
Patterson, T.L., Bucardo, J., McKibbin, C.L., et al., Development and pilot testing of a new psychosocial intervention for older Latinos with chronic psychosis. Schizophrenia Bulletin, 2005. 31(4): p. 922–30.CrossRefGoogle ScholarPubMed
Patterson, T.L., Mausbach, B.T., McKibbin, C., et al., Functional Adaptation Skills Training (FAST): A randomized trial of a psychosocial intervention for middle-aged and older patients with chronic psychotic disorders. Schizophrenia Research, 2006. 86(1-3): p. 291–9.CrossRefGoogle Scholar
Bartels, S.J., Pratt, S.I., Mueser, K.T., et al., Long-term outcomes of a randomized trial of integrated skills training and preventive healthcare for older adults with serious mental illness. American Journal of Geriatric Psychiatry, 2014. 22(11): p. 1251–61.CrossRefGoogle ScholarPubMed
Mueser, K.T., Pratt, S.I., Bartels, S.J., et al., Randomized trial of social rehabilitation and integrated health care for older people with severe mental illness. Journal of Consulting and Clinical Psychology, 2010. 78(4): p. 561–73.CrossRefGoogle ScholarPubMed
Meesters, P.D., Haan, L., Comijs, H.C., et al., Schizophrenia spectrum disorders in later life: prevalence and distribution of age at onset and sex in a Dutch catchment area. American Journal of Geriatric Psychiatry, 2012. 20(1): p. 18–28.CrossRefGoogle Scholar
Post, F., Schizo-affective symptomatology in late life. British Journal of Psychiatry, 1971. 118(545): p. 437–45.CrossRefGoogle ScholarPubMed
Baran, X.Y. and Young, R.C., Bipolar and depressive types of schizoaffective disorder in old age. American Journal of Geriatric Psychiatry, 2006. 14(4): p. 382–3.CrossRefGoogle ScholarPubMed
Kendler, K.S., Demography of paranoid psychosis (delusional disorder): a review and comparison with schizophrenia and affective illness. Archives of General Psychiatry, 1982. 39(8): p. 890–902.CrossRefGoogle ScholarPubMed
Maher, B., Delusional thinking and cognitive disorder. Integrative Physiological and Behavioral Science, 2005. 40(3): p. 136–46.CrossRefGoogle ScholarPubMed
Maglione, J.E., Vahia, I.V., and Jeste, D.V., Schizophrenia spectrum and other psychotic disorders. In The American Psychiatric Publishing Textbook of Geriatric Psychiatry, ed. Steffens, D.C., Blazer, D.G., and Thakur, M.E., 2015.Google Scholar
Mews, M.R. and Quante, A., Comparative efficacy and acceptability of existing pharmacotherapies for delusional disorder: a retrospective case series and review of the literature. Journal of Clinical Psychopharmacology, 2013. 33(4): p. 512–19.CrossRefGoogle ScholarPubMed
Byers, A.L., Yaffe, K., Covinsky, K.E., et al., High occurrence of mood and anxiety disorders among older adults: The National Comorbidity Survey Replication. Archives of General Psychiatry, 2010. 67(5): p. 489–96.CrossRefGoogle ScholarPubMed
Luppa, M., Sikorski, C., Luck, T., et al., Age- and gender-specific prevalence of depression in latest-life: systematic review and meta-analysis. Journal of Affective Disorders, 2012. 136(3): p. 212–21.CrossRefGoogle ScholarPubMed
Kessler, R.C., Berglund, P., Demler, O., et al., Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Archives of General Psychiatry, 2005. 62(6): p. 593–602.CrossRefGoogle ScholarPubMed
Brodaty, H., Luscombe, G., Parker, G., et al., Increased rate of psychosis and psychomotor change in depression with age. Psychological Medicine, 1997. 27(5): p. 1205–13.CrossRefGoogle ScholarPubMed
Bingham, K.S., Whyte, E.M., Meyers, B.S., et al., Relationship between cerebrovascular risk, cognition, and treatment outcome in late-life psychotic depression. American Journal of Geriatric Psychiatry, 2015. 23(12): p. 1270–5.CrossRefGoogle ScholarPubMed
Nelson, E.B., Psychotic depression: beyond the antidepressant/antipsychotic combination. Current Psychiatry Reports, 2012. 14(6): p. 619–23.CrossRefGoogle ScholarPubMed
Andreescu, C., Mulsant, B.H., Rothschild, A.J., et al., Pharmacotherapy of major depression with psychotic features: what is the evidence? Psychiatric Annals, 2006. 36(1): p. 31–8.Google Scholar
Geduldig, E.T. and Kellner, C.H., Electroconvulsive therapy in the elderly: new findings in geriatric depression. Current Psychiatry Reports, 2016. 18(4): p. 40.CrossRefGoogle ScholarPubMed
Wijkstra, J., Lijmer, J., Burger, H., et al., Pharmacological treatment for psychotic depression. Cochrane Database of Systematic Reviews, 2015(7): p. CD004044.Google ScholarPubMed
Leadholm, A.K., Rothschild, A.J., Nolen, W.A., et al., The treatment of psychotic depression: is there consensus among guidelines and psychiatrists? Journal of Affective Disorders, 2013. 145(2): p. 214–20.CrossRefGoogle ScholarPubMed
Meyers, B.S., Flint, A.J., Rothschild, A.J., et al., A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression. Archives of General Psychiatry, 2009. 66(8): p. 838–47.CrossRefGoogle ScholarPubMed
Rothschild, A.J., Williamson, D.J., Tohen, M.F., et al., A double-blind, randomized study of olanzapine and olanzapine/fluoxetine combination for major depression with psychotic features. Journal of Clinical Psychopharmacology, 2004. 24(4): p. 365–73.CrossRefGoogle ScholarPubMed
Young, R.C., Mulsant, B.H., Sajatovic, M., et al., GERI-BD: a randomized double-blind controlled trial of lithium and divalproex in the treatment of mania in older patients with bipolar disorder. American Journal of Psychiatry, 2017. 174(11): p. 1086–93.CrossRefGoogle ScholarPubMed
Rej, S., Yu, C., Shulman, K., et al., Medical comorbidity, acute medical care use in late-life bipolar disorder: a comparison of lithium, valproate, and other pharmacotherapies. General Hospital Psychiatry, 2015. 37(6): p. 528–32.CrossRefGoogle ScholarPubMed
Sajatovic, M. and Chen, P., Geriatric bipolar disorder. Psychiatric Clinics of North America, 2011. 34(2): p. 319–33.CrossRefGoogle ScholarPubMed
Sajatovic, M., Calabrese, J.R., and Mullen, J., Quetiapine for the treatment of bipolar mania in older adults. Bipolar Disorder, 2008. 10(6): p. 662–71.CrossRefGoogle ScholarPubMed
Sajatovic, M., Dines, P., Fuentes-Casiano, E., et al., Asenapine in the treatment of older adults with bipolar disorder. International Journal of Geriatric Psychiatry, 2015. 30(7): p. 710–19.CrossRefGoogle ScholarPubMed

References

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th edn. Arlington, VA: American Psychiatric Association, 2013.Google Scholar
Howard, R, Rabins, PV, Seeman, MV, Jeste, DV; The International Late-Onset Schizophrenia Group. Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: an international consensus. Am J Psychiatry. 2000; 157(2): 172–8. Consensus Development Conference Research Support, Non-U.S. Gov't Review.CrossRefGoogle ScholarPubMed
Jeste, DV, Lanouette, NM, Vahia, IV. Schizophrenia and paranoid disorders. In: Blazer, DG, Steffens, DC, eds., Textbook of Geriatric Psychiatry, 4th edn. Washington, DC: American Psychiatric Press, 2009: 317–31.Google Scholar
Girard, C, Simard, M. Elderly patients with very late-onset schizophrenia-like psychosis and early-onset schizophrenia: cross-sectional and retrospective clinical findings. Open J Psychiatry. 2012; 2: 305–16.CrossRefGoogle Scholar
Talaslahti, T, Alanen, HM, Hakko, H, et al. Patients with very-late-onset schizophrenia-like psychosis have higher mortality than elderly patients with earlier onset schizophrenia. Int J Geriatr Psychiatry. 2015; 30(5): 453–9.CrossRefGoogle ScholarPubMed
Seeman, MV. The role of estrogen in schizophrenia. J Psychiatry Neurosci. 1996; 21(2): 123–7.Google ScholarPubMed
Chua, WL, de Izquierdo, SA, Kulkarni, J, Mortimer, A. Estrogen for schizophrenia. Cochrane Database Syst Rev. 2005;(4): CD004719.Google ScholarPubMed
Kulkarni, J, Gavrilidis, E, Wang, W, et al. Estradiol for treatment-resistant schizophrenia: a large-scale randomized-controlled trial in women of child-bearing age. Mol Psychiatry. 2015; 20(6): 695–702.CrossRefGoogle ScholarPubMed
Kulkarni, J, Gavrilidis, E, Gwini, SM, et al. Effect of adjunctive raloxifene therapy on severity of refractory schizophrenia in women: a randomized clinical trial. JAMA Psychiatry. 2016; 73(9): 947–54.CrossRefGoogle Scholar
Palmer, BW, Bondi, MW, Twamley, EW, et al. Are late-onset schizophrenia spectrum disorders neurodegenerativ conditions? Annual rates of change on two dementia measures. J Neuropsychiatry Clin Neurosci. 2003; 15(1): 45–52.CrossRefGoogle Scholar
Maglione, JE, Thomas, SE, Jeste, DV. Late-onset schizophrenia: do recent studies support categorizing LOS as a subtype of schizophrenia? Curr Opin Psychiatry. 2014; 27(3): 173–8.CrossRefGoogle ScholarPubMed
Jeste, DV, Symonds, LL, Harris, MJ, et al. Nondementia nonpraecox dementia praecox? Late-onset schizophrenia. Am J Geriatr Psychiatry. 1997; 5(4): 302–17.CrossRefGoogle ScholarPubMed
Jeste, DV, Harris, MJ, Krull, A, et al. Clinical and neuropsychological characteristics of patients with late-onset schizophrenia. Am J Psychiatry. 1995; 152(5): 722–30.Google ScholarPubMed
Vahia, IV, Palmer, BW, Depp, C, et al. Is late-onset schizophrenia a subtype of schizophrenia? Acta Psychiatr Scand. 2010; 122: 414–426.CrossRefGoogle ScholarPubMed
Girard, C, Simard, M. Clinical characterization of late- and very late-onset first psychotic episode in psychiatric inpatients. Am J Geriatr Psychiatry. 2008; 16(6): 478–87.CrossRefGoogle ScholarPubMed
Köhler, S, van der Werf, M, Hart, B, et al. Evidence that better outcome of psychosis in women is reversed with increasing age of onset: a population-based 5-year follow-up study. Schizophr Res. 2009; 113(2): 226–32.CrossRefGoogle ScholarPubMed
Hassett, A. A descriptive study of first presentation psychosis in old age. Aus NZ J Psychiatry. 1999; 33(6): 814–24.CrossRefGoogle ScholarPubMed
Reeves, S, Stewart, R, Howard, R. Service contact and psychopathology in very-late-onset schizophrenia-like psychosis: the effects of gender and ethnicity. Int J Geriat Psychiatry. 2002; 17: 473–9.CrossRefGoogle ScholarPubMed
Heaton, RK, Gladsjo, JA, Palmer, BW, et al. Stability and course of neuropsychological deficits in schizophrenia. Arch Gen Psychiatry. 2001; 58(1): 24–32.CrossRefGoogle ScholarPubMed
Rajji, TK, Mulsant, BH. Nature and course of cognitive function in late-life schizophrenia: a systematic review. Schizophr Res. 2008; 102(1): 122–40.CrossRefGoogle ScholarPubMed
Heaton, R, Paulsen, JS, McAdams, LA, et al. Neuropsychological deficits in schizophrenics: relationship to age, chronicity, and dementia. Arch Gen Psychiatry. 1994; 51(6): 469–76.CrossRefGoogle ScholarPubMed
Rajji, TK, Ismail, Z, Mulsant, BH. Age at onset and cognition in schizophrenia: meta-analysis. Br J Psychiatry. 2009; 195(4): 286–93.CrossRefGoogle ScholarPubMed
Kørner, A, Lopez, AG, Lauritzen, L, Andersen, PK, Kessing, LV. Late and very-late first-contact schizophrenia and the risk of dementia – a nationwide register based study. Int J Geriatr Psychiatry 2009; 24: 61–7.CrossRefGoogle ScholarPubMed
Lagodka, A, Robert, P. Is late-onset schizophrenia related to neurodegenerative processes? A review of literature. Encephale 2009; 35: 386–93.Google ScholarPubMed
Brodaty, H, Sachdev, P, Koschera, A, Monk, D, Cullen, B. Long-term outcome of late-onset schizophrenia: 5-year follow-up study. Br J Psychiatry 2003; 183: 213–9.CrossRefGoogle ScholarPubMed
Hahn, C, Lim, HK, Lee, CU. Neuroimaging findings in late-onset schizophrenia and bipolar disorder. J Geriatr Psychiatry Neurol 2014; 27: 56–62.CrossRefGoogle ScholarPubMed
Rivkin, P, Kraut, M, Barta, P, et al. White matter hyperintensity volume in late-onset and early-onset schizophrenia. Int J Geriat Psychiatry. 2000; 15: 1085–9.3.0.CO;2-X>CrossRefGoogle ScholarPubMed
Barta, PE, Powers, RE, Aylward, EH, et al. Quantitative MRI volume changes in late onset schizophrenia and Alzheimer's disease compared to normal controls. Psychiat Res Neuroim. 1997; 68(2): 65–75.CrossRefGoogle Scholar
Sachdev, P, Brodaty, H. Quantitative study of signal hyperintensities on T2-weighted magnetic resonance imaging in late-onset schizophrenia. Am J Psychiatry. 1999: 156(12): 1958–67.CrossRefGoogle ScholarPubMed
Corey-Bloom, J, Jernigan, T, Archibald, S, Harris, MJ, Jeste, DV. Quantitative magnetic resonance imaging of the brain in late-life schizophrenia. Am J Psychiatry. 1995; 152(3): 447–9.Google ScholarPubMed
Chen, L, Chen, X, Liu, W, et al. White matter microstructural abnormalities in patients with late-onset schizophrenia identified by a voxel-based diffusion tensor imaging. Psychiat Res Neuroim. 2013; 212(3): 201–7.CrossRefGoogle ScholarPubMed
Kubicki, M, Styner, M, Bouix, S, et al. Reduced interhemispheric connectivity in schizophrenia: tractography based segmentation of the corpus callosum. Schizophr Res. 2008; 106(2–3): 125–31.CrossRefGoogle ScholarPubMed
Jones, DK, Catani, M, Pierpaoli, C, et al. A diffusion tensor magnetic resonance imaging study of frontal cortex connections in very-late-onset schizophrenia-like psychosis. Am J Ger Psychiatr. 2005; 13(12): 1092–9.CrossRefGoogle ScholarPubMed
Howard, R, Graham, C, Sham, P, et al. A controlled family study of late-onset non-affective psychosis (late paraphrenia). Br J Psychiatry. 1997; 170: 511–14.CrossRefGoogle ScholarPubMed
Rasmussen, HB, Timm, S, Wang, AG, et al. Association between the CCR5 32-bp deletion allele and late onset of schizophrenia. Am J Psychiatry. 2006; 163(3): 507–11.CrossRefGoogle ScholarPubMed
Benros, ME, Nielsen, PR, Nordentoft, M, et al. Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study. Am J Psychiatry. 2011; 168(12): 1303–10.CrossRefGoogle ScholarPubMed
Wium-Andersen, MK, Ørsted, DD, Nordestgaard, BG. Elevated C-reactive protein associated with late- and very-late-onset schizophrenia in the general population: a prospective study. Schizophrenia Bull. 2014; 40(5): 1117–27.CrossRefGoogle ScholarPubMed
Jeste, DV. Late-onset schizophrenia. Int J Geriat Psychiatry. 1993; 8: 283–5.CrossRefGoogle Scholar
Linszen, MM, Brouwer, RM, Heringa, SM, Sommer, IE. Increased risk of psychosis in patients with hearing impairment: Review and meta-analyses. Neurosci Biobehav Rev. 2016; 62: 1–20.CrossRefGoogle ScholarPubMed
Essali, A, Ali, G. Antipsychotic drug treatment for elderly people with late-onset schizophrenia. Cochrane Database Syst Rev. 2012;(2): CD004162.Google ScholarPubMed
Scott, J, Greenwald, BS, Kramer, E, Shuwall, M. Atypical (second generation) antipsychotic treatment response in very late-onset schizophrenia-like psychosis. Int Psychogeriatr. 2011; 23: 742–48.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×